Insider · CIK 0002089362
Peter George Colis
Files at LIFE (Ethos Technologies Inc.). First filing Sep 18, 2026, latest Sep 18, 2026.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LIFE: Ethos Technologies Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | Ethos Technologies Inc. | $2.7M 70,000 shares | -4% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | LIFE Ethos Technologies Inc. | CConversion Class A Common Stock10b5-1 | +23,334 | - | - | 1,560,694 | 24 d ago |
| Sep 16, 2026 | LIFE Ethos Technologies Inc. | SOpen-market sale Class A Common Stock10b5-1 | -21,363 | $39.77 | $850k | 1,539,331 | 24 d ago |
| Sep 16, 2026 | LIFE Ethos Technologies Inc. | SOpen-market sale Class A Common Stock10b5-1 | -1,971 | $40.35 | $80k | 1,537,360 | 24 d ago |
| Sep 17, 2026 | LIFE Ethos Technologies Inc. | CConversion Class A Common Stock10b5-1 | +23,333 | - | - | 1,560,693 | 24 d ago |
| Sep 17, 2026 | LIFE Ethos Technologies Inc. | SOpen-market sale Class A Common Stock10b5-1 | -1,900 | $37.69 | $72k | 1,558,793 | 24 d ago |
| Sep 17, 2026 | LIFE Ethos Technologies Inc. | SOpen-market sale Class A Common Stock10b5-1 | -21,118 | $38.94 | $822k | 1,537,675 | 24 d ago |
| Sep 17, 2026 | LIFE Ethos Technologies Inc. | SOpen-market sale Class A Common Stock10b5-1 | -315 | $39.67 | $12k | 1,537,360 | 24 d ago |
| Sep 18, 2026 | LIFE Ethos Technologies Inc. | CConversion Class A Common Stock10b5-1 | +23,333 | - | - | 1,560,693 | 24 d ago |
| Sep 18, 2026 | LIFE Ethos Technologies Inc. | SOpen-market sale Class A Common Stock10b5-1 | -7,190 | $35.98 | $259k | 1,553,503 | 24 d ago |
| Sep 18, 2026 | LIFE Ethos Technologies Inc. | SOpen-market sale Class A Common Stock10b5-1 | -9,648 | $37.05 | $357k | 1,543,855 | 24 d ago |
| Sep 18, 2026 | LIFE Ethos Technologies Inc. | SOpen-market sale Class A Common Stock10b5-1 | -6,495 | $37.52 | $244k | 1,537,360 | 24 d ago |
| Sep 16, 2026 | LIFE Ethos Technologies Inc. | CConversion Class B Common Stockderivative10b5-1 | -23,334 | $0.00 | $0 | 6,131,347 | 24 d ago |
| Sep 17, 2026 | LIFE Ethos Technologies Inc. | CConversion Class B Common Stockderivative10b5-1 | -23,333 | $0.00 | $0 | 6,108,014 | 24 d ago |
| Sep 18, 2026 | LIFE Ethos Technologies Inc. | CConversion Class B Common Stockderivative10b5-1 | -23,333 | $0.00 | $0 | 6,084,681 | 24 d ago |
| Jan 29, 2026 | LIFE Ethos Technologies Inc. | FTax withholding Class A Common Stock | -562,993 | $0.00 | $0 | 6,965,866 | Jan 30, 2026 |
| Jan 30, 2026 | LIFE Ethos Technologies Inc. | CConversion Class A Common Stock | -6,154,683 | $0.00 | $0 | 811,183 | Jan 30, 2026 |
| Jan 30, 2026 | LIFE Ethos Technologies Inc. | CConversion Class A Common Stockindirect: by trust | -128,893 | $0.00 | $0 | 0 | Jan 30, 2026 |
| Jan 30, 2026 | LIFE Ethos Technologies Inc. | CConversion Class A Common Stockindirect: by trust | -214,822 | $0.00 | $0 | 0 | Jan 30, 2026 |
| Jan 30, 2026 | LIFE Ethos Technologies Inc. | CConversion Class B Common Stockderivative | +6,154,683 | $0.00 | $0 | 6,154,683 | Jan 30, 2026 |
| Jan 30, 2026 | LIFE Ethos Technologies Inc. | CConversion Class B Common Stockderivativeindirect: by trust | +128,893 | $0.00 | $0 | 128,893 | Jan 30, 2026 |
| Jan 30, 2026 | LIFE Ethos Technologies Inc. | CConversion Class B Common Stockderivativeindirect: by trust | +214,822 | $0.00 | $0 | 214,822 | Jan 30, 2026 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.